A citation-based method for searching scientific literature

T Langheinrich, L Tebartz van Elst, W A Lagrèze, M Bach, C H Lücking, M W Greenlee. Clin Neurophysiol 2000
Times Cited: 57







List of co-cited articles
553 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Visual dysfunction in Parkinson's disease. Loss in spatiotemporal contrast sensitivity.
I Bodis-Wollner, M S Marx, S Mitra, P Bobak, L Mylin, M Yahr. Brain 1987
229
42

Decreased dopamine in the retinas of patients with Parkinson's disease.
C Harnois, T Di Paolo. Invest Ophthalmol Vis Sci 1990
247
42



Retinal nerve fiber layer thinning in Parkinson disease.
Rivka Inzelberg, Jose Antonio Ramirez, Puiu Nisipeanu, Avinoam Ophir. Vision Res 2004
224
29


Dopamine and retinal function.
Paul Witkovsky. Doc Ophthalmol 2004
513
28

The retina in Parkinson's disease.
Neil K Archibald, Michael P Clarke, Urs P Mosimann, David J Burn. Brain 2009
221
28


Alteration of visual evoked potentials and electroretinograms in Parkinson's disease.
I Gottlob, E Schneider, W Heider, W Skrandies. Electroencephalogr Clin Neurophysiol 1987
96
26

Neurobiology of retinal dopamine in relation to degenerative states of the tissue.
M B Djamgoz, M W Hankins, J Hirano, S N Archer. Vision Res 1997
196
26

Abnormalities in color vision and contrast sensitivity in Parkinson's disease.
M J Price, R G Feldman, D Adelberg, H Kayne. Neurology 1992
174
24


Electrophysiology and optical coherence tomography to evaluate Parkinson disease severity.
Elena Garcia-Martin, Diego Rodriguez-Mena, Maria Satue, Carmen Almarcegui, Isabel Dolz, Raquel Alarcia, Maria Seral, Vicente Polo, Jose M Larrosa, Luis E Pablo. Invest Ophthalmol Vis Sci 2014
67
24

Decreased color discrimination and contrast sensitivity in Parkinson's disease.
V Pieri, N J Diederich, R Raman, C G Goetz. J Neurol Sci 2000
103
22



Morphologic changes and functional retinal impairment in patients with Parkinson disease without visual loss.
Marilita M Moschos, Georgios Tagaris, Ioannis Markopoulos, Ioannis Margetis, Stylianos Tsapakis, Menelaos Kanakis, Chrysanthi Koutsandrea. Eur J Ophthalmol 2011
111
22

Correlation between retinal morphological and functional findings and clinical severity in Parkinson's disease.
Ozgül Altintaş, Pervin Işeri, Berna Ozkan, Yusuf Cağlar. Doc Ophthalmol 2008
154
22

Visual evoked cortical potentials and pattern electroretinograms in Parkinson's disease and control subjects.
S Nightingale, K W Mitchell, J W Howe. J Neurol Neurosurg Psychiatry 1986
89
21

Inner retinal layer thinning in Parkinson disease.
Mohammedyusuf E Hajee, Wayne F March, Douglas R Lazzaro, Arthur H Wolintz, Eric M Shrier, Sofya Glazman, Ivan G Bodis-Wollner. Arch Ophthalmol 2009
180
21


Low contrast stimuli enhance PERG sensitivity to the visual dysfunction in Parkinson's disease.
A Peppe, P Stanzione, F Pierelli, E Stefano, P A Rizzo, M Tagliati, C Morocutti. Electroencephalogr Clin Neurophysiol 1992
23
43

Progressive worsening of spatial and chromatic processing deficits in Parkinson disease.
Nico J Diederich, Rema Raman, Sue Leurgans, Christopher G Goetz. Arch Neurol 2002
92
17

The pattern electroretinogram in Parkinson's disease reveals lack of retinal spatial tuning.
M Tagliati, I Bodis-Wollner, M D Yahr. Electroencephalogr Clin Neurophysiol 1996
72
17

Does pattern electroretinogram spatial tuning alteration in Parkinson's disease depend on motor disturbances or retinal dopaminergic loss?
A Peppe, P Stanzione, M Pierantozzi, R Semprini, A Bassi, A M Santilli, R Formisano, M Piccolino, G Bernardi. Electroencephalogr Clin Neurophysiol 1998
43
23

Independent patterns of damage within magno-, parvo- and koniocellular pathways in Parkinson's disease.
M F Silva, P Faria, F S Regateiro, V Forjaz, C Januário, A Freire, M Castelo-Branco. Brain 2005
91
17

Impairment of high-contrast visual acuity in Parkinson's disease.
R D Jones, I M Donaldson, P L Timmings. Mov Disord 1992
52
19

Seeing gray when feeling blue? Depression can be measured in the eye of the diseased.
Emanuel Bubl, Elena Kern, Dieter Ebert, Michael Bach, Ludger Tebartz van Elst. Biol Psychiatry 2010
74
17

The retina as a window to the brain-from eye research to CNS disorders.
Anat London, Inbal Benhar, Michal Schwartz. Nat Rev Neurol 2013
465
17


Dopaminergic neurons in the human retina.
J M Frederick, M E Rayborn, A M Laties, D M Lam, J G Hollyfield. J Comp Neurol 1982
222
15

Visual system abnormalities in patients with Parkinson's disease.
M J Kupersmith, E Shakin, I M Siegel, A Lieberman. Arch Neurol 1982
85
15

Acquired colour deficiency in patients with Parkinson's disease.
J Birch, R U Kolle, M Kunkel, W Paulus, P Upadhyay. Vision Res 1998
32
28

Phosphorylated α-synuclein-immunoreactive retinal neuronal elements in Parkinson's disease subjects.
Thomas G Beach, Jeremiah Carew, Geidy Serrano, Charles H Adler, Holly A Shill, Lucia I Sue, Marwan N Sabbagh, Haruhiko Akiyama, Nicolás Cuenca. Neurosci Lett 2014
78
15

Dopaminergic modulation of visual sensitivity in man.
G Masson, D Mestre, O Blin. Fundam Clin Pharmacol 1993
79
14

MPTP produces reversible disappearance of tyrosine hydroxylase-containing retinal amacrine cells.
W G Tatton, M M Kwan, M C Verrier, N A Seniuk, E Theriault. Brain Res 1990
77
14


Effect of levodopa treatment on contrast sensitivity in Parkinson's disease.
C Bulens, J D Meerwaldt, G J Van der Wildt, J B Van Deursen. Ann Neurol 1987
75
14

Chromatic pattern-reversal electroretinograms (ChPERGs) are spared in multiple system atrophy compared with Parkinson's disease.
F Sartucci, G Orlandi, U Bonuccelli, D Borghetti, L Murri, C Orsini, L Domenici, V Porciatti. Neurol Sci 2006
26
30

Detection of retinal changes in Parkinson's disease with spectral-domain optical coherence tomography.
Grant D Aaker, Jane S Myung, Joshua R Ehrlich, Mujtaba Mohammed, Claire Henchcliffe, Szilárd Kiss. Clin Ophthalmol 2010
86
14

Retinal thickness in Parkinson's disease.
N K Archibald, M P Clarke, U P Mosimann, D J Burn. Parkinsonism Relat Disord 2011
82
14

Optical coherence tomography in parkinsonian syndromes.
Philipp Albrecht, Ann-Kristin Müller, Martin Südmeyer, Stefano Ferrea, Marius Ringelstein, Eva Cohn, Orhan Aktas, Thomas Dietlein, Alexandra Lappas, Andreas Foerster,[...]. PLoS One 2012
116
14

Effect of antidepressive therapy on retinal contrast processing in depressive disorder.
Emanuel Bubl, Dieter Ebert, Elena Kern, Ludger Tebartz van Elst, Michael Bach. Br J Psychiatry 2012
39
20

Retinal nerve fiber layer thickness and visual hallucinations in Parkinson's Disease.
Jee-Young Lee, Jae Min Kim, Jeeyun Ahn, Han-Joon Kim, Beom S Jeon, Tae Wan Kim. Mov Disord 2014
72
14

Bioelectrical function and structural assessment of the retina in patients with early stages of Parkinson's disease (PD).
Barbara Nowacka, Wojciech Lubiński, Krystyna Honczarenko, Andrzej Potemkowski, Krzysztof Safranow. Doc Ophthalmol 2015
26
30

α-synuclein in the inner retina in parkinson disease.
Ivan Bodis-Wollner, Piotr B Kozlowski, Sofya Glazman, Shahnaz Miri. Ann Neurol 2014
100
14

Correlation of inner retinal thickness evaluated by spectral-domain optical coherence tomography and contrast sensitivity in Parkinson disease.
Christopher R Adam, Eric Shrier, Yin Ding, Sofya Glazman, Ivan Bodis-Wollner. J Neuroophthalmol 2013
61
14

Spatiotemporal contrast sensitivity differs in normal aging and Parkinson's disease.
D Mestre, O Blin, G Serratrice, J Pailhous. Neurology 1990
62
12

Temporal frequency-dependent VEP changes in Parkinson's disease.
M Marx, I Bodis-Wollner, P Bobak, C Harnois, L Mylin, M Yahr. Vision Res 1986
43
16


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.